Thursday, 24 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Drug
Antengene Files for Xpovio Approval in Macau, Malaysia, and Thailand
January 27, 2025
Drug
Eisai and Biogen Initiate BLA in China for Alzheimer’s Therapy Lecanemab
January 27, 2025
Company
Deals
Qitan Tech Raises RMB 700 Million in Series C Financing Led by Meituan
January 27, 2025
Company
Drug
Kanghong’s Escitalopram Oral Solution Receives NMPA Marketing Approval
January 27, 2025
Company
Drug
Tonghua Dongbao Receives NMPA Approval for THDBH151 Clinical Study in Gout and Hyperuricemia
January 27, 2025
Company
Deals
Innovent Biologics Announces Strategic Partnerships to Form Tumor Diagnosis and Treatment Alliance
January 27, 2025
Company
Drug
BioNTech Ships First COVID-19 Vaccine Batches to China
January 28, 2025
Company
Drug
Merck Launches Noxafil in China for Antifungal Treatment
January 27, 2025
Company
Drug
Hinova’s PROTAC Drug HP518 Accepted for FDA Review in mCRPC
January 27, 2025
Company
Drug
Fosun Kite’s CAR-T Therapy FKC889 Approved for Clinical Trials in China
January 27, 2025
Policy / Regulatory
Shanghai Outlines Plans to Boost Healthcare and Pharma Industry
January 27, 2025
Company
Drug
Yantai Dongcheng Receives NMPA Approval for F18 PET Imaging Study
January 27, 2025
1
2
…
1,069
1,070
1,071
1,072
1,073
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?